We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
http://www.cambridge-news.co.uk/Business/Private-Punter/Sagentia-turnaround-beds-solid-footing-in-20140513111812.htm This was published in May. He said that Sag is trading at around a forward PER of 16 so may look further valued but cash accounts for 48p etc so there's clearly still value here. Well worth a read
EV/EBIT is not high at all. Sub 8 is cheap in my book :)
Since I last considered this 2 months ago the price has dropped and how I calculate the EV/EBIT ratio has changed so things now look like this: Good points The P/E ratio is undemanding at 10.9 The EV/EBIT ratio is a little high at 7.8 and ...considering that profit increased 65% YoY it looks excellent! SAG is in superb financial health. This share is even more cash-rich than before. The cash pile accounts for 42.5% of the MC and, comparing it to (MC + Liabilities), it still stands at a very impressive 37%. Operative margins of almost 19% show that SAG have some serious pricing power / a good niche. The company has experienced 4 years of growth after many years of losses, and this turnaround has happened during an economically difficult period. This bodes well for the future and really shows how talented the BoD are. Bad points / reasons for caution: H1 2013 was exceptionally good therefore the upcoming H1 2014 results will almost certainly going to show profit before tax and EPS to have fallen year on year. By my calculations, and taking into account that H1 seems to be a stronger period than H2 (that's been true of 2012 and 2013), I reckon 2014 Revenue will be roughly £34m (up YoY), profit before tax will be £4.8m (down YoY), and EPS will be roughly 11.6p (down YoY). In other words - I think SAG looks much cheaper than it truly is due to an exceptionally good year we cannot reasonably expect to continue. Conclusion SAG is still good value / cheap but it's not as cheap as I first thought and, whilst I was eager to buy into SAG before the H1 2014 results before, I'm less keen now. I think I'll hold off for now, see how things play out (I'm expecting a bit of a drop), and then go from there. Thoughts, anyone?
tight
Never did that research but, looking at the share price, maybe I was best off not doing so yet. But, haven given this another look following the 2013 FY results, this does look very good. The P/E ratio is undemanding at 11.5 The EV/EBIT ratio is a little high at 10.6 but... ...considering that profit increased 65% YoY it still looks very good Above all I am very tempted by the fact that this is such a cash-rich share. The cash pile accounts for 40% of the MC and, comparing it to (MC + Liabilities), it still stands at a very impressive 30%. It's nice that this also pays a dividend but, considering how well covered it is, I'm surprised it is not higher. It therefore suggests that acquisitions are on the way because it'd be silly to not make use of the cash pile in any way. Obviously haven't research this hugely but I have to say it is looking more than good!
I can't say it looks undervalued but it is growing nicely and the new london office may well accelerate that growth further perhaps. May do some research here soon...
Summary · Group revenue increased by 37% to £30.6 million (2012: £22.3 million) · Organic revenue growth of 27% to £28.2 million (excluding businesses acquired in year) · Adjusted* operating profit increased by 48% to £5.7 million (2012: £3.9 million) · Group profit-before-tax increased by 65% to £4.9 million (2012: £3.0 million) · Adjusted* diluted EPS increased by 34% to 12.2 pence (2012: 9.1 pence). Statutory diluted EPS of 11.2 pence (2012: 7.5 pence) · Gross cash of £22.4 million (2012: £19.2 million) and net funds of £12.6 million (2012: £12.9 million) after £3.8 million net cash expenditure on acquisitions during the year · Proposed dividend of 1.1 pence per share (2012: 1.0 pence)
Sagentia Group plc (AIM:SAG), the international technology consulting company, announces that the Group will be issuing its Preliminary Results for the year ended 31 December 2013 on Wednesday 5 March 2014.
http://www.theel1tetrader.com/2014/02/sagentia-what-is-fair-value.html?showComment=1392023281160
A pretty fair summary from privatepunter. Thanks for that, lets hope we see steady and sustained progress during 2014.
Doesn't appear to have a great following this one, but a decent perfomer. may interest those who follow http://www.privatepunter.co.uk/Companies/sagentia-26-december-2013
Thanks for the comment, it was getting a bit lonely on here! I have to agree that it is not the most exciting share around, but it does look pretty solid. Hopefully not subject to the violent swings that some AIM shares have. SAG is building a reputation for being a trustworthy company, it would probably not be in their interests to stitch up the shareholders! Perhaps a relatively safe haven, some are looking for that kind of share with all the tax advantages AIM provides. We'll see!
SAG is beautiful imv...but the really fun part for punters is largely behind us
Sagentia has been recruited by a Silicon Valley biomedical pioneer to develop a device to fight inflammatory diseases. http://www.businessweekly.co.uk/biomedtech-/16244-sagentia-technology-to-fight-inflammatory-disease
http://www.onlinetmd.com/sagentia-medical-device-development.aspx
http://www.brandon-medical.com/products/medical-lighting/operating-lights/quasar-hd-led
The price is drifting down despite some positive news items in recent weeks. The company looks in pretty good shape at the moment. I could think of worse places to put money at this price.
http://www.businessweekly.co.uk/biomedtech-/16162-sagentia-unveils-surgical-lighting-technology
Graeme Hall, CEO of Brandon Medical, comments: “At Brandon Medical, we are aiming to create truly innovative products that will delight our customers. The new operating theatre lights and medical room lights that we’ve designed with Sagentia really meet these goals and we’re already working together on the next new product!”
Breakthrough Medical Lighting "Dr Euan Morrison, Head of Advanced Lighting & Optical Technologies at Sagentia, said: “Once again the successful partnership between Brandon Medical and Sagentia has led to the development of some truly ground breaking medical lighting technology. In particular, the optical design incorporated into these products uses an innovative new type of optical element that we have developed which delivers superb beam profiles and also enables our unique solid state focusing approach. The combination of this along with some recent advances which we have made in colour rendition using LEDs has delivered a great new technology platform for Brandon Medical.”" http://www.sagentia.com/news/press-releases-and-news/2013/breakthrough-surgical-lighting-technology-launched-at-medica.aspx
Alliance News Sagentia Expects In Line Performance For Full Year, Finance Director Steps Down Tue, 12th Nov 2013 13:03 LONDON (Alliance News) - Technology consulting company Sagentia Group PLC said Tuesday that it anticipates its full-year performance to be in line with forecasts given during its interim results, as trading in the second half continued to meet expectations. Additionally, Finance Director Neil Elton is stepping down from the company. He will be succeeded by Rebecca Hemsted, who currently works as business finance partner for the managed services business of RM PLC. Sagentia said Elton will hand over to Hemsted early in the new year. Shares in Sagentia were trading down 1.00 pence at 150.00 pence Tuesday. By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Dan Edwards, Managing Director at Sagentia’s HealthTech Advisory division: ”By 2025 healthcare spend and technology innovation will increasingly focus on predicting, diagnosing and monitoring, compared with today’s strong focus on treating,” says Dan Edwards. “The prime driver for this shift will be that in catching disease earlier in its lifecycle – in some cases before symptoms present – we will reduce the cost of health. We will also see healthcare becoming more consumer-led and a migration of healthcare away from traditional high-cost environments to the home. This means we’ll see the market entry of companies which are consumer and service savvy. Traditional MedTech companies are really struggling to adapt their approach to business to fit with the emerging connected healthcare opportunity and the field is ripe for new entrants to steal a lead in this booming market.” http://www.sagentia.com/news/press-releases-and-news/2013/sagentia-joins-silicon-valley-thought-leaders-to-discuss-the-future-of-healthcare.aspx
Recruiting for; "our rapidly growing Industrial sector." http://www.sagentia.com/careers/vacancies.aspx
"Trading in the second half of the current financial year has reflected the Board's expectations at the time of the Interim Results. Performance for the year to 31 December 2013 is therefore anticipated to be in line with the upgrade at that time. The integration of OTM Consulting Limited, acquired on 8 July 2013, is progressing satisfactorily." Steady as she goes, with encouraging growth. A trading update that seems to underline the ambiance that is becoming synonymous with Sagentia, that of it being a safe pair of hands. Long may it continue!